Filtern
Erscheinungsjahr
- 2007 (1)
Dokumenttyp
Sprache
- Englisch (1)
Volltext vorhanden
- nein (1)
Gehört zur Bibliographie
- nein (1)
Schlagworte
- Economics (1) (entfernen)
Former economic analyses have shown that universal mass vaccination of infants against varicella using a one-dose schedule is cost-saving in Germany. In July 2006, an MMRV combination vaccine has been approved in Germany which shall be given in a two-dose schedule. We re-analysed our former analysis with the EVITA model in order to prove whether our former conclusion that universal mass vaccination against varicella is cost-saving is still valid when using a two-dose schedule vaccine. Indeed we found that universal mass vaccination of infants against varicella with a two-dose vaccine is cost-saving from societal as well as from health care perspective.